Related Experiment Video
Updated: Jan 11, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients
L Bianchi1,2, A Mottaran3, B Bortolani4
1Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy. lorenzo.bianchi3@gmail.com.
Augmented reality (AR)-PSMA-3D guided pelvic lymph node dissection (PLND) facilitates the resection of lymph node metastases (LNM) in prostate cancer patients. This novel technique improves intraoperative identification of suspicious LNM, even those outside the standard dissection template.
Area of Science:
- Urology
- Oncology
- Medical Imaging
Background:
- Accurate intraoperative identification of lymph node metastases (LNM) during robot-assisted radical prostatectomy (RARP) with pelvic lymph node dissection (PLND) is crucial for optimal surgical outcomes in prostate cancer (PCa) patients.
- Preoperative PSMA-PET imaging is vital for detecting LNM, but real-time intraoperative guidance for precise dissection remains a challenge.
Purpose of the Study:
- To describe and evaluate a novel augmented reality (AR)-PSMA-3D guided PLND technique.
- To assess the feasibility of real-time intraoperative identification and resection of suspicious LNM detected by PSMA-PET during RARP.
Main Methods:
- Prospective enrollment of thirteen high-risk PCa patients with suspected lymph node metastases (miN1-2 or miM1a) at PSMA-PET.
- Creation of a 3D segmentation model of suspicious LNM from preoperative PSMA-PET images.
- Performance of RARP with AR-PSMA-3D guided PLND for real-time intraoperative guidance, with pathologic examination as the reference standard.
Main Results:
- AR-PSMA-3D guided PLND successfully facilitated the dissection of suspicious LNM, including four cases (30%) outside the standard PLND template, without intraoperative complications.
- Pathologic examination confirmed pN1 disease in nine patients (69%), with three (23%) having metastases outside the PLND template.
- Per-region analysis demonstrated high performance for AR-PSMA-3D guided PLND, with sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of 69%, 90%, 52%, 95%, and 0.79, respectively.
Conclusions:
- AR-PSMA-3D guidance for PLND is a promising technique for facilitating the resection of suspicious LNM in PCa patients with PSMA-PET detected metastases, including those outside the conventional PLND template.
- The technique enables real-time identification of suspicious nodes, potentially improving surgical precision.
- Limitations include the spatial resolution of PSMA-PET for micro-metastases and the need for manual alignment of the 3D model.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020